🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of avelumab ...
Status
Active Not Recruiting
Location
Beacon Cancer Care
Start Date
2022-08-17
Trial ID
NCT05327530
Treatments Being Tested
To learn about the effects of the investigational drug NKTR-255 in combinat...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-01-10
Trial ID
NCT05632809
Treatments Being Tested
The goal of this Phase 1 clinical study is test tumor infiltrating lymphocy...
Status
Terminated
Location
Ochsner MD Anderson Cancer Center
Start Date
2024-02-29
Trial ID
NCT05676749
Treatments Being Tested
This phase I trial studies the side effects of CD19/CD22 chimeric antigen r...
Status
Active Not Recruiting
Location
Stanford University, School of Medicine
Start Date
2017-09-01
Trial ID
NCT03233854
Patients will receive intravenous (IV) NKTR-255 in 21 or 28 day treatment c...
Status
Completed
Location
Western Regional Medical Center - CTCA
Start Date
2019-10-07
Trial ID
NCT04136756
Treatments Being Tested
This is a Phase 1b/2, open-label multicenter study evaluating NKTR-255 as a...
Status
Completed
Location
University of California, San Diego
Start Date
2020-10-30
Trial ID
NCT04616196
This study will evaluate the safety and efficacy of NKTR-255 following CD19...
Status
Terminated
Location
University of California San Diego
Start Date
2022-12-23
Trial ID
NCT05664217
Treatments Being Tested
This phase Ib trial studies the effects of NKTR-255 in combination with chi...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-12-08
Trial ID
NCT05359211
Treatments Being Tested